Hydrochlorothiazide

Product NDC: 0591-0347
11-digit product format: 005910347
Labeler code: 0591
Product ID: 0591-0347_b062bc7e-af92-4648-aed1-e02568313e21
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Hydrochlorothiazide
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Labeler: Actavis Pharma, Inc.
Application: NDA020504
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 1996-12-27
Substance: HYDROCHLOROTHIAZIDE
Active strength: 12.5 mg/1
Pharmacologic classes: Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
unfinished product	product	0591-0347		UNFINISHED	Active or certified unfinished drug listing	2026-08-17
unfinished package	package	0591-0347	0591-0347-00	UNFINISHED	Active or certified unfinished drug listing	2026-08-17
unfinished package	package	0591-0347	0591-0347-77	UNFINISHED	Active or certified unfinished drug listing	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 53 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	0591-0347-77	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	0591-0347-00	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	0591-0347-00	`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	0591-0347-77	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	0591-0347-00	`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	0591-0347-77	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	0591-0347-00	`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	0591-0347-77	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	0591-0347-00	`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	0591-0347-77	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	0591-0347-00	`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	0591-0347-77	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	0591-0347-00	`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	0591-0347-77	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	0591-0347-00	`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	0591-0347-77	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	0591-0347-00	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	0591-0347-77	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	0591-0347-00	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	0591-0347-77	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	0591-0347-00	`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	0591-0347-77	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	0591-0347-00	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	0591-0347-00	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	0591-0347-00	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	0591-0347-00	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	0591-0347-00	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	0591-0347-00	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	0591-0347-00	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	0591-0347-00	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	0591-0347-00	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		`5b2001dcd8f5…`	`54b53d4dc9e4…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished package	package	0591-0347-00	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020504-001	MICROZIDE	HYDROCHLOROTHIAZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N020504-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020504-001	MICROZIDE	12.5MG	CAPSULE / ORAL	AB	RLD, RS	1996-12-27	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N020504-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020504-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020504-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020504-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020504-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020504-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020504-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020504-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020504-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020504-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020504-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020504-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020504-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020504-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020504-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020504-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020504-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020504-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020504-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020504-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020504-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020504-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020504-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020504-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020504-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020504-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020504-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020504-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020504-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020504-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020504-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020504-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020504-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020504-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020504-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020504-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020504-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020504-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020504-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020504-001	AB	1	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Hydrochlorothiazide
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
HYDROCHLOROTHIAZIDE	12.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0J48LPH2TH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199903	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a3eb7294-f913-434b-896c-da028bfebc73	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0591-0347-01	Hydrochlorothiazide	100 in 1 BOTTLE	CAPSULE, GELATIN COATED	100		24
0591-0347-05	Hydrochlorothiazide	500 in 1 BOTTLE	CAPSULE, GELATIN COATED	500		24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0591-0347-01	EA - Each	0591-0347	c9282ce9-22fd-4fa7-81cf-de180d8770f4	1	2012-07-24
0591-0347-05	EA - Each	0591-0347	1a2d2b20-68f7-4659-b5bf-f697687ef4db	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	11
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PD-RX PHARMACEUTICALS, INC.]	10
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	7
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PREFERRED PHARMACEUTICALS INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [BLENHEIM PHARMACAL, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [STAT RX USA LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [PROFICIENT RX LP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0591-0347	HYDROCHLOROTHIAZIDE CAPSULE, GELATIN COATED [ACTAVIS PHARMA, INC.]	21	Current NDC, Legacy NDC, 2 package rows	20240509_a3eb7294-f913-434b-896c-da028bfebc73.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	QPharma, Inc.	5bacc909-6b02-4815-85ef-55fd25b1b1f7	2025-12-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020504 application number: NDA020504
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Actavis Pharma, Inc.	a3eb7294-f913-434b-896c-da028bfebc73	2024-08-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020504 application number: NDA020504 ndc (product): 0591-0347
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Proficient Rx LP	c1052d38-fd75-40c2-a685-0e889009be0b	2023-02-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020504 application number: NDA020504
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Aphena Pharma Solutions - Tennessee, LLC	0f7a608d-748b-49a9-a4b3-b3fdcab53ce0	2017-12-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020504 application number: NDA020504

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	a3eb7294-f913-434b-896c-da028bfebc73	24
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	a3eb7294-f913-434b-896c-da028bfebc73	24
199903	HCTZ 12.5 MG Oral Capsule	SY	a3eb7294-f913-434b-896c-da028bfebc73	24
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	5bacc909-6b02-4815-85ef-55fd25b1b1f7	8
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	5bacc909-6b02-4815-85ef-55fd25b1b1f7	8
199903	HCTZ 12.5 MG Oral Capsule	SY	5bacc909-6b02-4815-85ef-55fd25b1b1f7	8
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	c1052d38-fd75-40c2-a685-0e889009be0b	6
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	c1052d38-fd75-40c2-a685-0e889009be0b	6
199903	HCTZ 12.5 MG Oral Capsule	SY	c1052d38-fd75-40c2-a685-0e889009be0b	6
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	0f7a608d-748b-49a9-a4b3-b3fdcab53ce0	1
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	118f7c88-dd50-25d5-e054-00144ff88e88	1
199903	hydroCHLOROthiazide 12.5 MG Oral Capsule	PSN	1576a4be-c3ec-426e-9219-c6a0c99f294f	1
310798	hydroCHLOROthiazide 25 MG Oral Tablet	PSN	118f7c88-dd6e-25d5-e054-00144ff88e88	1
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	1576a4be-c3ec-426e-9219-c6a0c99f294f	1
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	118f7c88-dd50-25d5-e054-00144ff88e88	1
199903	hydrochlorothiazide 12.5 MG Oral Capsule	SCD	0f7a608d-748b-49a9-a4b3-b3fdcab53ce0	1
310798	hydrochlorothiazide 25 MG Oral Tablet	SCD	118f7c88-dd6e-25d5-e054-00144ff88e88	1
199903	HCTZ 12.5 MG Oral Capsule	SY	0f7a608d-748b-49a9-a4b3-b3fdcab53ce0	1
199903	HCTZ 12.5 MG Oral Capsule	SY	1576a4be-c3ec-426e-9219-c6a0c99f294f	1
199903	HCTZ 12.5 MG Oral Capsule	SY	118f7c88-dd50-25d5-e054-00144ff88e88	1
310798	HCTZ 25 MG Oral Tablet	SY	118f7c88-dd6e-25d5-e054-00144ff88e88	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0591-0347-00	00591034700	28085 CAPSULE, GELATIN COATED in 1 BOX (0591-0347-00)	27-DEC-96				Current
0591-0347-01	00591034701	100 CAPSULE, GELATIN COATED in 1 BOTTLE (0591-0347-01)	1996-12-27	0000-00-00	No	No	Current
0591-0347-05	00591034705	500 CAPSULE, GELATIN COATED in 1 BOTTLE (0591-0347-05)	1996-12-27	0000-00-00	No	No	Current
0591-0347-77	00591034777	28085 CAPSULE, GELATIN COATED in 1 CONTAINER (0591-0347-77)	01-AUG-24				Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Hydrochlorothiazide Capsules, USP	QPharma, Inc. \| Actavis Pharma, Inc. \| Northwind Health Company, LLC	2025-12-05	HUMAN PRESCRIPTION DRUG LABEL	8
Hydrochlorothiazide Capsules, USP	Actavis Pharma, Inc. \| Watson Pharma Private Limited	2024-08-01	HUMAN PRESCRIPTION DRUG LABEL	24
Hydrochlorothiazide Capsules, USP Revised: October 2011 Rx only	Proficient Rx LP	2023-02-01	HUMAN PRESCRIPTION DRUG LABEL	6
Hydrochlorothiazide Capsule	PD-Rx Pharmaceuticals, Inc.	2022-03-14	HUMAN PRESCRIPTION DRUG LABEL	22
Hydrochlorothiazide Capsule	NuCare Pharmaceuticals,Inc.	2021-02-15	HUMAN PRESCRIPTION DRUG LABEL	2
Hydrochlorothiazide Capsule	Bryant Ranch Prepack	2020-10-16	HUMAN PRESCRIPTION DRUG LABEL	3
Hydrochlorothiazide Capsule	Aphena Pharma Solutions - Tennessee, LLC	2017-12-21	HUMAN PRESCRIPTION DRUG LABEL	1
Hydrochlorothiazide Capsule	Preferred Pharmaceuticals Inc.	2017-02-02	HUMAN PRESCRIPTION DRUG LABEL	2
Hydrochlorothiazide Capsules, USP Revised: October 2011 Rx only 174788-3	Blenheim Pharmacal, Inc. \| Blenheim Pharamcal, Inc.	2015-03-18	HUMAN PRESCRIPTION DRUG LABEL	1
Hydrochlorothiazide Capsules, USP Revised: October 2011 Rx only 174788-3	Blenheim Pharmacal, Inc.	2015-03-18	HUMAN PRESCRIPTION DRUG LABEL	1
Hydrochlorothiazide Capsules	NCS HealthCare of KY, Inc dba Vangard Labs	2015-01-06	HUMAN PRESCRIPTION DRUG LABEL	7
Hydrochlorothiazide Capsules Revised: March 2009 Rx only 174788	STAT RX USA LLC	2010-05-21	HUMAN PRESCRIPTION DRUG LABEL	1